They say no bad news is good news. For Wall Street, on certain days, no news is also good news. Futures market are in the green after the S&P 500 and Nasdaq gained for the third day in a row. The Dow Jones also ended 500 points higher in regular trading on Thursday.

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the third quarter of fiscal 2025 were $2.37, up 11.3% year over year. The metric beat the Zacks Consensus Estimate by 0.4%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.

Shares of Resmed Inc. (RMD) traded over 7% higher in pre-market on Thursday morning after the company’s third-quarter earnings beat Wall Street estimates and the firm dismissed the impact from the Trump administration’s imposition of tariffs on imports.

The stock market tumbled Monday as Wall Street grapples with ongoing tariff uncertainty and President Trump's attacks on Jerome Powell.

U.S. markets are poised to open with big gains, a clear sign of relief after President Donald Trump said he would not attempt to fire the head of the Federal Reserve